Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/16/2018 |
| Start Date: | April 2009 |
| End Date: | December 2017 |
The objectives of this multinational study are to assess the clinical outcomes of patients
with Acinetobacter bloodstream infection and to further assess the predictors of mortality in
this patient population. We also aim to characterize the molecular epidemiology of this
remarkable organism in an attempt to further understand its transmission dynamics on a global
level and to determine whether increased pathogenicity is geographically dependent.
with Acinetobacter bloodstream infection and to further assess the predictors of mortality in
this patient population. We also aim to characterize the molecular epidemiology of this
remarkable organism in an attempt to further understand its transmission dynamics on a global
level and to determine whether increased pathogenicity is geographically dependent.
Medical records will be reviewed and information collected to assess the clinical outcomes of
patients with Acinetobacter bloodstream infection and to further assess the predictors of
mortality in this patient population.
patients with Acinetobacter bloodstream infection and to further assess the predictors of
mortality in this patient population.
Inclusion Criteria:
- Patients with Acinetobacter infections
Exclusion Criteria:
- Those that do not meet entry criteria
We found this trial at
1
site
200 Lothrop St
Pittsburgh, Pennsylvania 15213
Pittsburgh, Pennsylvania 15213
Principal Investigator: David Paterson, MD
Phone: 412-648-6553
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
Click here to add this to my saved trials
